O-propargyl-puromycin (OPP) for Protein Synthesis
2026-08-14
Use O-propargyl-puromycin (OPP) to quantify nascent protein production in B cells, stress models, and proteomics workflows with single-cell or imaging resolution. Its click-compatible alkyne enables flexible fluorescence and enrichment readouts that complement mitochondrial and antibody-production assays.
JNJ-26854165: Smarter p53 Assay Design
2026-08-13
JNJ-26854165 (Serdemetan) is an HDM2-targeting research compound for studying p53 stabilization, growth inhibition, and apoptosis. This guide advances beyond compound descriptions by showing how endpoint selection can distinguish cytostasis from true cell killing in cancer research.
BH3 Mimetics Clear Senescent Breast Cancer Cells
2026-08-13
Shahbandi and colleagues show that chemotherapy-induced senescent breast cancer cells can retain a selective dependence on BCL-XL or BCL-XL/MCL1 despite their nonproliferative state. In TP53 wild-type models, BH3 mimetic treatment after chemotherapy promoted apoptosis, improved tumor regression, and extended survival, providing a mechanistic strategy for addressing residual disease.
L-Threonine: From Nutrient Flux to Assay Confidence
2026-08-12
L-Threonine is more than a media component: it is a controllable input for studying amino acid sensing, protein synthesis, central carbon metabolism, and assay robustness. This translational guide connects L-Threonine perturbation with metabolic profiling and metal-free alkaline phosphatase detection while defining the controls needed to separate biological effects from analytical interference.
Halazone: From Chlorine Chemistry to Assay Design
2026-08-12
Halazone is an antimicrobial sulfonamide derivative whose value depends on controlling reactive chlorine chemistry and interpreting biological readouts in context. This article translates its water-disinfection and sodium-current evidence into practical assay-design decisions.
Temafloxacin Against Gram-Negative Bacteria: Key Findings
2026-08-11
This review examines how temafloxacin compared with ciprofloxacin and ofloxacin across respiratory pathogens, Enterobacteriaceae, sexually transmitted disease agents, and less common Gram-negative bacteria. Its main contribution is a structured in vitro spectrum analysis that identifies strong activity against many organisms while highlighting the relative weakness of temafloxacin against Pseudomonas aeruginosa.
Amplex Red for Redox Assay Design
2026-08-10
Amplex Red converts hydrogen peroxide-dependent oxidation into a measurable resorufin fluorescence signal. This guide connects reactive oxygen species detection with the iron gate and enzyme latch framework, showing how assay controls can improve redox interpretation in complex biological and wetland matrices.
Levofloxacin: From Target to Assay Signal
2026-08-09
Levofloxacin is a synthetic fluoroquinolone antibiotic whose assay behavior depends on both DNA gyrase inhibition and resistance-gene context. This guide connects molecular activity, CREC transmission evidence, and bone-cell endpoints to improve experimental interpretation.
Iron Gate vs. Enzyme Latch in Mangrove SOC
2026-08-08
Zhao and colleagues examine whether water-regulated soil organic carbon preservation in mangrove wetlands is controlled mainly by phenolic enzyme inhibition or by iron redox processes. Their 60-day incubation study indicates that the iron gate mechanism is the stronger regulator, while high water content suppresses early carbon mineralization but later promotes release of iron-bound carbon under reducing conditions.
Carbapenemase Gene Transmission in CREC
2026-08-07
This 2025 BMC Microbiology study maps carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae collected from eight teaching hospitals in Guangdong, China. By combining gene localization, conjugation, mobile-element analysis, antimicrobial susceptibility testing, and strain typing, it shows that blaNDM-1 is both prevalent and highly transferable across clinical isolates.
Cefepime (BMY-28142): Applied Workflows for CNS Infection Mo
2026-08-07
Cefepime (BMY-28142) stands out for its robust blood-brain barrier penetration, enabling rigorous research into central nervous system infections and multidrug-resistant bacteria. This guide details advanced protocols, troubleshooting strategies, and comparative insights to help researchers maximize experimental clarity and reproducibility.
Linezolid (SKU A5181): Advancing Gram-Positive Research Reli
2026-08-06
This article provides scenario-driven guidance for biomedical researchers using Linezolid (SKU A5181) in cell viability, proliferation, and cytotoxicity assays. Drawing on APExBIO's validated product data and recent literature, it addresses experimental design, protocol optimization, data interpretation, and vendor reliability, ensuring reproducible and data-backed workflows in Gram-positive bacterial research.
Cefodizime: Third-Generation Cephalosporin Antibiotic Data S
2026-08-06
Cefodizime is a third-generation cephalosporin antibiotic exhibiting broad-spectrum activity and pronounced β-lactamase stability. It inhibits bacterial cell wall synthesis via penicillin-binding protein targeting. This dossier presents quantitative benchmarks, mechanistic rationale, and workflow integration guidance for research use.
Cefodizime: Third-Generation Cephalosporin Antibiotic Profil
2026-08-05
Cefodizime is a third-generation cephalosporin antibiotic with broad-spectrum antibacterial activity and β-lactamase stability. Its mechanism targets bacterial cell wall synthesis via penicillin-binding proteins, making it effective for respiratory and urinary tract pathogens. The compound is kidney-safe and demonstrates immunomodulatory properties, with robust evidence for research use.
Cell Surface Integrity Sets Ploidy Limits in Budding Yeast
2026-08-05
The reference study uncovers how physical properties of the cell surface restrict the maximum achievable ploidy in Saccharomyces cerevisiae. By experimentally manipulating polyploidization and surface stress, the authors link cell integrity to genome content and highlight the physiological trade-offs facing polyploid cells.
466 records 9/32 page Previous Next First page 上5页 678910 下5页 Last page